Importantly, RIPK1 has been shown to regulate the expression of CH25H, a key enzyme in lipid metabolism, and its downstream product 25-hydroxycholesterol, thereby affecting transcriptional profiles in the AD brain. This evidence concerns the gene CH25H and Alzheimer disease.